Back
Regeneron Pharmaceuticals Quote, Financials, Valuation and Earnings
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Sell
37
REGN
Regeneron Pharmaceuticals
Last Price:
828.82
Seasonality Move:
12.34%
7 Day Trial
ALL ACCESS PASS
$
7
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE TradeRegeneron Pharmaceuticals Price Quote
$828.82
-0.05 (-1.75%)
(Updated: November 5, 2024 at 3:09 AM ET)
Regeneron Pharmaceuticals Key Stats
Sell
37
Regeneron Pharmaceuticals (REGN)
is a Sell
Day range:
$826.76 - $852.01
52-week range:
$783.57 - $1,211.20
Dividend yield:
0%
P/E ratio:
23.84
P/S ratio:
6.89
P/B ratio:
3.11%
Volume:
638.7K
Avg. volume:
794.3K
1-year change:
1.47%
Market cap:
$91.1B
Revenue:
$13.1B
EPS:
$40.41
How Much Does Regeneron Pharmaceuticals Make?
-
How Much Are Regeneron Pharmaceuticals's Sales Annually?
REGN Revenues are $13.1B -
How Much Profit Does Regeneron Pharmaceuticals's Make A Year?
REGN net income is $4B
Is Regeneron Pharmaceuticals Growing As A Company?
-
What Is Regeneron Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.11% -
What Is Regeneron Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0.3%
Regeneron Pharmaceuticals Stock Price Performance
-
Did Regeneron Pharmaceuticals Stock Go Up Last Month?
Regeneron Pharmaceuticals share price went down by -18.16% last month -
Did REGN's Share Price Rise Over The Last Year?
REGN share price rose by 1.47% over the past 1 year
What Is Regeneron Pharmaceuticals 52-Week High & Low?
-
What Is Regeneron Pharmaceuticals’s 52-Week High Share Price?
Regeneron Pharmaceuticals has traded as high as $1,211.20 over the past 52 weeks -
What Is Regeneron Pharmaceuticals’s 52-Week Low Share Price?
Regeneron Pharmaceuticals has traded as low as $783.57 over the past 52 weeks
Regeneron Pharmaceuticals Price To Free Cash Flow
-
Is Regeneron Pharmaceuticals Stock Overvalued?
Regeneron Pharmaceuticals is trading at a price to free cash flow ratio of 28.74 -
Is Regeneron Pharmaceuticals Stock Undervalued?
Regeneron Pharmaceuticals EV to Free Cash Flow ratio is 25.09 -
What Is Regeneron Pharmaceuticals’s Price Earnings Growth Ratio?
REGN PEG ratio is 1.34 -
Is Regeneron Pharmaceuticals Trading At A Premium To Earnings?
Regeneron Pharmaceuticals EV to EBIT ratio is 16.55
Is It Risky To Buy Regeneron Pharmaceuticals?
-
How Much Debt Does Regeneron Pharmaceuticals Have?
Total long term debt quarterly is $2B -
How Much Cash Does Regeneron Pharmaceuticals Have?
Cash and short term investments quarterly total is $9.8B -
What Is Regeneron Pharmaceuticals’s Book Value Per Share?
Book value per share is 266.32
Is Regeneron Pharmaceuticals Cash Flow Positive?
-
What Is REGN Cash Flow From Operations?
Cash flow from operations (TTM) is $4.2B -
What Is Regeneron Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$1.5B -
What Is Regeneron Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$2.9B
Regeneron Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
REGN return on invested capital is 16.02% -
What Is Regeneron Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is 13.44% -
What Is REGN Return On Equity?
ROE is a measure of profitability and is 17.19%
Regeneron Pharmaceuticals Earnings Date & Stock Price
-
What Is Regeneron Pharmaceuticals's Stock Price Today?
A single share of REGN can be purchased today for 828.87 -
What Is Regeneron Pharmaceuticals’s Stock Symbol?
Regeneron Pharmaceuticals trades on the S&P500 under the ticker symbol: REGN -
When Is Regeneron Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Regeneron Pharmaceuticals is scheduled on January 31, 2025 -
When Is REGN's next ex-dividend date?
Regeneron Pharmaceuticals's next ex-dividend date is November 5, 2024 -
How To Buy Regeneron Pharmaceuticals Stock?
You can buy Regeneron Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Regeneron Pharmaceuticals Competitors
-
Who Are Regeneron Pharmaceuticals's Competitors?
Below is a list of companies who compete with Regeneron Pharmaceuticals or are related in some way:
Regeneron Pharmaceuticals Dividend Yield
-
What Is REGN Dividend Yield?
Regeneron Pharmaceuticals’s dividend yield currently is 0% -
What Is Regeneron Pharmaceuticals’s Payout Ratio?
Regeneron Pharmaceuticals’s payout ratio is 0% -
When Did Regeneron Pharmaceuticals Last Pay A Dividend?
The latest dividend pay date is November 5, 2024 -
What Is Regeneron Pharmaceuticals’s Dividend Per Share?
Regeneron Pharmaceuticals pays a dividend of $0.00 per share
Regeneron Pharmaceuticals Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 29.81% | 6.38% |
| Revenue: | 10.65% | 1.47% |
Analyst Recommendations
| Buy Recommendations: | 10 |
|---|---|
| Hold Recommendations: | 5 |
| Sell Recommendations: | 0 |
| Price Target: | 1,095.43 |
| Upside from Last Price: | 32.16% |